Hopkinson Craig C.

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 12. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 12
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Alkermes plc.EVP R&D, Chief Medical OfficerOption exercisenothing paid5,000 sharesSep 1, 2026Alkermes plc.EVP R&D, Chief Medical Officernothing paidExercise · Sep 1Option exercise5,000Sep 1, 2026
Alkermes plc.EVP R&D, Chief Medical OfficerOpen-market sell$422,8749,000 sharesSep 1, 2026Alkermes plc.EVP R&D, Chief Medical Officer$422,874Sell · Sep 1Open-market sell9,000Sep 1, 2026
Alkermes plc.EVP R&D, Chief Medical OfficerOption exercise$122,9505,000 sharesSep 1, 2026Alkermes plc.EVP R&D, Chief Medical Officer$122,950Exercise · Sep 1Option exercise5,000Sep 1, 2026
Alkermes plc.EVP R&D, Chief Medical OfficerOption exercisenothing paid4,896 sharesAug 3, 2026Alkermes plc.EVP R&D, Chief Medical Officernothing paidExercise · Aug 3Option exercise4,896Aug 3, 2026
Alkermes plc.EVP R&D, Chief Medical OfficerOption exercisenothing paid104 sharesAug 3, 2026Alkermes plc.EVP R&D, Chief Medical Officernothing paidExercise · Aug 3Option exercise104Aug 3, 2026